Abstract
We recently developed a novel expression system employing the halophilic Archaeon Halobacterium sp. NRC-1 for scaled-up production and nanoparticle-display of antigenic proteins. Here, we have targeted the major human parasite Plasmodium falciparum circumsporozoite protein (CSP), which is of interest for formulation of a protective malaria vaccine. A codon-optimized synthetic gene coding the full-length CSP was inserted downstream of the strong promoter for gvpA, the major gas vesicle nanoparticle protein gene, in the pDRK expression vector, and as a fusion to the gvpC protein in the pSD expression vector for display on the surface of gas vesicle nanoparticles. We found that the pDRK-CSP expression plasmid programmed high-level production of full-length CSP and the pSD-CSP expression plasmid programmed production of a GvpC-CSP fusion protein, for display on gas vesicle nanoparticles. The Halobacterium sp. expression system provides a novel approach and a potentially valuable technical advancement for the production of P. falciparum CSP for malaria vaccine development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Berquist BR, Müller JA, DasSarma S (2006) Chapter 27. Genetic systems for halophilic archaea. In: Oren A, Rainey F (eds) Methods in microbiology, vol 35. Elsevier/Academic Press, Amsterdam, pp 649–680
Bowman NM, Congdon S, Mvalo T, Patel JC, Escamilla V, Emch M, Martinson F, Hoffman I, Meshnick SR, Juliano JJ (2013) Comparative population structure of Plasmodium falciparum circumsporozoite protein NANP repeat lengths in Lilongwe, Malawi. Sci Rep 3:1990
Campo JJ, Sacarlal J, Aponte JJ, Aide P, Nhabomba AJ, Dobaño C, Alonso PL (2014) Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS, S/AS02 in Mozambique. Vaccine 32(19):2209–2216. doi:10.1016/j.vaccine.2014.02.042
Childs TS, Webley WC (2012) In vitro assessment of halobacterial gas vesicles as a Chlamydia vaccine display and delivery system. Vaccine 30(41):5942–5948
Coppi A, Natarajan R, Pradel G, Bennett BL, James ER, Roggero MA, Corradin G, Persson C, Tewari R, Sinnis P (2011) The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host. J Exp Med 208(2):341–356
Dame JB, Williams JL, McCutchan TF, Weber JL, Wirtz RA, Hockmeyer WT, Maloy WL, Haynes JD, Schneider I, Roberts D, Sanders GS, Reddy EP, Diggs CL, Miller LH (1984) Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 225(4662):593–599
DasSarma S (2004) Genome sequence of an extremely halophilic archaeon. In: Fraser CM, Read T, Nelson KE (eds) Microbial genomes. Humana Press, Totowa, pp 383–399
DasSarma S (2007) Extreme microbes: the salty side of life. Am Sci 95(3):224–231
DasSarma S, Arora P (1997) Genetic analysis of the gas vesicle gene cluster in haloarchaea. FEMS Microbiol Lett 153(1):1–10
DasSarma S, DasSarma P (2015) Gas vesicle nanoparticles for antigen display. Vaccines 3(3):686–702
DasSarma S, Halladay JT, Jones JG, Donovan JW, Giannasca PJ, Tandeau de Marsac N (1988) High-frequency mutations in a plasmid-encoded gas vesicle gene in Halobacterium halobium. Proc Natl Acad Sci U S A 85(18):6861–6865
DasSarma S, Robb FT, Place AR, Sowers KR, Schreier HJ, Fleischmann EM (eds) (1995) Archaea: a laboratory manual – halophiles. Cold Spring Harbor Laboratory Press, Plainview
DasSarma P, Coker JA, Huse V, DasSarma S (2010) Halophiles, industrial applications. In: Flickinger MC (ed) Encyclopedia of industrial biotechnology: bioprocess, bioseparation, and cell technology. Wiley, Hoboken, pp 1–43
DasSarma S, Karan R, DasSarma P, Barnes S, Ekulona F, Smith B (2013) An improved genetic system for bioengineering buoyant gas vesicle nanoparticles from haloarchaea. BMC Biotechnol 13:112. doi:10.1186/1472-6750-13-112
DasSarma P, Negi VD, Balakrishnan A, Karan R, Barnes S, Ekulona F, Chakravortty D, DasSarma S (2014) Haloarchaeal gas vesicle nanoparticles displaying Salmonella SopB antigen reduce bacterial burden when administered with live attenuated bacteria. Vaccine 32(35):4543–4549
del Portillo HA, Nussenzweig RS, Enea V (1987) Circumsporozoite gene of a Plasmodium falciparum strain from Thailand. Mol Biochem Parasitol 24(3):289–294
Karan R, Capes MD, DasSarma P, DasSarma S (2013) Cloning, overexpression, purification, and characterization of a polyextremophilic β-galactosidase from the Antarctic haloarchaeon Halorubrum lacusprofundi. BMC Biotechnol 13:3. doi:10.1186/1472-6750-13-3
Karan R, DasSarma P, Balcer-Kubiczek E, Weng RR, Liao C-C, Goodlett DR, Ng WV, DasSarma S (2014) Bioengineering radioresistance by overproduction of RPA, a mammalian-type single-stranded DNA-binding protein, in a halophilic archaeon. Appl Microbiol Biotechnol 98(4):1737–1747
Kastenmüller K, Espinosa DA, Trager L, Stoyanov C, Salazar AM, Pokalwar S, Singh S, Dutta S, Ockenhouse CF, Zavala F, Seder RA (2013) Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I · C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mice. Infect Immun 81(3):789–800
Kennedy SP, Ng WV, Salzberg SL, Hood L, DasSarma S (2001) Understanding the adaptation of Halobacterium species NRC-1 to its extreme environment through computational analysis of its genome sequence. Genome Res 11:1641–1650
Kolodny N, Kitov S, Vassell MA, Miller VL, Ware LA, Fegeding K, De La Vega P, Sacci JB Jr, Lanar DE (2001) Two-step chromatographic purification of recombinant Plasmodium falciparum circumsporozoite protein from Escherichia coli. J Chromatogr B Biomed Sci Appl 762(1):77–86
Ménard R, Tavares J, Cockburn I, Markus M, Zavala F, Amino R (2013) Looking under the skin: the first steps in malarial infection and immunity. Nat Rev Microbiol 11(10):701–712
Mo AX, Augustine AD (2014) NIAID meeting report: improving malaria vaccine strategies through the application of immunological principles. Vaccine 32(10):1132–1138
Ng WV, Ciufo SA, Smith TM, Bumgarner RE, Baskin D, Faust J, Hall B, Loretza C, Seto J, Slagel J, Hood L, DasSarma S (1998) Snapshot of a large dynamic replicon in a halophilic archaeon: megaplasmid or minichromosome? Genome Res 8:1131–1141
Ng WV, Kennedy SP, Mahairas GG, Berquist B, Pan M, Shukla HD, Lasky SR, Baliga NS, Thorsson V, Sbrogna J, Swartzell S, Weir D, Hall J, Dahl TA, Welti R, Goo YA, Leithauser B, Keller K, Cruz R, Danson MJ, Hough DW, Maddocks DG, Jablonski PE, Krebs MP, Angevine CM, Dale H, Isenbarger TA, Peck RF, Pohlschroder M, Spudich JL, Jung K-H, Alam M, Freitas T, Hou S, Daniels CJ, Dennis PP, Omer AD, Ebhardt H, Lowe TM, Liang P, Riley M, Hood L, DasSarma S (2000) Genome sequence of Halobacterium species NRC-1. Proc Natl Acad Sci U S A 97(22):12176–12181
Nussenzweig V, Nussenzweig RS (1989) Rationale for the development of an engineered sporozoite malaria vaccine. Adv Immunol 45:283–334
Plassmeyer ML, Reiter K, Shimp RL Jr, Kotova S, Smith PD, Hurt DE, House B, Zou X, Zhang Y, Hickman M, Uchime O, Herrera R, Nguyen V, Glen J, Lebowitz J, Jin AJ, Miller LH, MacDonald NJ, Wu Y, Narum DL (2009) Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. J Biol Chem 284:26951–26963
Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, Nussenzweig V (1987) γ interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330(6149):664–666
Sedegah M, Kim Y, Ganeshan H, Huang J, Belmonte M, Abot E, Banania JG, Farooq F, McGrath S, Peters B, Sette A, Soisson L, Diggs C, Doolan D, Tamminga C, Villasante E, Hollingdale MR, Richie T (2013) Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP). Malar J 12:185
Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, Richman A, Chakravarty S, Manoj A, Velmurugan S, Li ML, Ruben AJ, Li T, Eappen AG, Stafford RE, Plummer SH, Hendel CS, Novik L, Costner PJM, Mendoza FH, Saunders JG, Nason MC, Richardson JH, Murphy J, Davidson SA, Richie T, Sedegah M, Sutamihardja A, Fahle GA, Lyke KE, Laurens MB, Roeder M, Tewari K, Epstein JE, Sim BKL, Ledgerwood JE, Graham BS, Hoffman SL, the VRC 312 Study Team (2013) Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341(6152):1359–1365
Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68(5):850–858
Shukla HD, DasSarma S (2004) Complexity of gas vesicle biogenesis in Halobacterium sp. strain NRC-1: identification of five new proteins. J Bacteriol 186(10):3182–3186
Sremac M, Stuart ES (2008) Recombinant gas vesicles from Halobacterium sp. displaying SIV peptides demonstrate biotechnology potential as a pathogen peptide delivery vehicle. BMC Biotechnol 8:9
Sremac M, Stuart ES (2010) SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation. BMC Biotechnol 10:54
Stuart ES, Sremac M, Morshed F, DasSarma S (2001) Antigen presentation using novel particulate organelles from halophilic archaea. J Biotechnol 88(2):119–128
Stuart ES, Morshed F, Sremac M, DasSarma S (2004) Cassette-based presentation of SIV epitopes with recombinant gas vesicles from halophilic archaea. J Biotechnol 114(3):225–237
Wirtz RA, Zavala F, Charoenvit Y, Campbell GH, Burkot TR, Schneider I, Esser KM, Beaudoin RL, Andre RG (1987) Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development. Bull World Health Organ 65(1):39–45
Young JF, Hockmeyer WT, Gross M, Ballou WR, Wirtz RA, Trosper JH, Beaudoin RL, Hollingdale MR, Miller LH, Diggs CL, Rosenberg M (1985) Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine. Science 228(4702):958–962
Acknowledgments
This work was supported by Bill & Melinda Gates Foundation grant OPP1061509, and National Institutes of Health grant R03 AI107634 to SD and National Institutes of Health grant R01 AI056840 to PS. JK was supported by the PKNU Research Abroad Fund CD-2013-0914. We thank Susan Barnes and Folasade Ekulona for technical assistance, Stefanie Trop and Peter Dumoulin for valuable discussions, and Prof. F. Zavala for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
Wolf T. Pecher, Jong-Myoung Kim, Priya DasSarma, Ram Karan, Photini Sinnis, and Shiladitya DasSarma declare that they have no conflict of interest.
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Pecher, W.T., Kim, JM., DasSarma, P., Karan, R., Sinnis, P., DasSarma, S. (2016). Halobacterium Expression System for Production of Full-Length Plasmodium falciparum Circumsporozoite Protein. In: Rampelotto, P. (eds) Biotechnology of Extremophiles:. Grand Challenges in Biology and Biotechnology, vol 1. Springer, Cham. https://doi.org/10.1007/978-3-319-13521-2_25
Download citation
DOI: https://doi.org/10.1007/978-3-319-13521-2_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13520-5
Online ISBN: 978-3-319-13521-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)